Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency

Abstract

Objective: It remains controversial whether long-term glucocorticoids are charged of bone demineralization in patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. The aim of this study was to know whether cumulative glucocorticoid dose from the diagnosis in childhood to adulthood in patients with CAH had a negative impact on bone mineral density (BMD). Design: This was a retrospective study. Methods: Thirty-eight adult patients with classical and non-ctassical CAH were included. BMD was measured in the lumbar spine and femoral neck. Total cumulative glucocorticoid (TCG) and total average glucocorticoid (TAG) doses were calculated from pediatric and adult files. Results: We showed a difference between final and target heights (-0.82±0.92 S.D. for women and -1.31±0.84 S.D. for men; P <0.001). Seventeen patients (44.7%) had bone dernincralization (35.7% of women and 70% of men). The 28 women had higher BMD than the 10 men for lumbar (-0.26±1.20 vs -1.25±1.33 S.D.; P = 0.02) and femoral T-scores (0.21±1.30 S.D. versus -1.08±1.10 S.D.; P=0.007). In the salt-wasting group, women were almost significantly endowed with a better BMD than men (P=0.053). We found negative effects of TCG, TAG on lumbar (P <0.001, P=0.002) and femoral T-scores (P=0.006, P <0.001), predominantly during puberty. BMI was protective on BMD (P =0.006). Conclusion: The TCG is an important factor especially during puberty for a bone demineralization in patients with 21-hydroxylase deficiency. The glucocorticoid treatment should be adapted particularly at this life period and preventive measures should be discussed in order to limit this effect. © 2008 Society of the European Journal of Endocrinology.